Showing results (1751-1760 of 1,840) with videos related to

Sort By:
Pageof 184
Signal Transduction and Targeted Therapy|August 8, 2024
Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosisHan Yan, Wenjun Liu, Rui Xiang, et al.
Signal Transduction and Targeted Therapy|September 22, 2024
Single-cell exome sequencing reveals polyclonal seeding and TRPS1 mutations in colon cancer metastasisJianqiang Cai, Weilong Zhang, Yalan Lu, et al.
Signal Transduction and Targeted Therapy|September 26, 2024
Surufatinib plus toripalimab combined with etoposide and cisplatin as first-line treatment in advanced small-cell lung cancer patients: a phase Ib/II trialYaxiong Zhang, Yan Huang, Yunpeng Yang, et al.
Signal Transduction and Targeted Therapy|August 1, 2024
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progressionZedong Jiang, Qianlong Kang, Hong Qian, et al.
Signal Transduction and Targeted Therapy|May 11, 2025
Viral oncogenesis in cancer: from mechanisms to therapeuticsQing Xiao, Yi Liu, Tingting Li, et al.
Signal Transduction and Targeted Therapy|May 18, 2025
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectivesChunsik Lee, Myung-Jin Kim, Anil Kumar, et al.
Signal Transduction and Targeted Therapy|May 15, 2025
Platelets and diseases: signal transduction and advances in targeted therapyYuchen Tian, Yao Zong, Yidan Pang, et al.
Signal Transduction and Targeted Therapy|May 22, 2025
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II studyMengqing Xie, Minwei Bao, Xiaorong Dong, et al.
Signal Transduction and Targeted Therapy|May 4, 2025
Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemiaJuan Xie, Xue-Fei Liu, Tong Zhou, et al.
Signal Transduction and Targeted Therapy|April 29, 2025
Multipronged SMAD pathway targeting by lipophilic poly(β-amino ester) miR-590-3p nanomiRs inhibits mesenchymal glioblastoma growth and prolongs survivalJack Korleski, Sophie Sall, Kathryn M Luly, et al.
Pageof 184